Chandrajit Premanand Raut, MD, MSC

Chief, Division of Surgical Oncology, Mass General Brigham
Surgery Director, Sarcoma Disease Program, Mass General Brigham Cancer Institute 
Endowed Chair for Cancer Care, Department of Surgery, Brigham and Women’s Hospital
Surgeon-in-Chief and Chair, Department of Surgery, Dana-Farber Cancer Institute
Surgery Director, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Richard E. Wilson, MD Professor of Surgery in the Field of Surgical Oncology, Harvard Medical School

Dr. Raut is a dedicated surgical oncologist who specializes in the multidisciplinary care of patients with soft tissue sarcoma.  He is a prolific researcher who has received federal funding to investigate sarcoma tumor genetics and identify strategies at reducing sarcoma recurrence rates.  Additionally, he has served as co-PI or institutional PI on several US and international phase 2 or phase 3 clinical trials evaluating neoadjuvant or adjuvant therapies in various sarcomas.  

Dr. Raut is a graduate of Stanford University, University of Oxford, and Harvard Medical School.  He completed his general surgery residency at Massachusetts General Hospital and surgical oncology fellowship at M.D. Anderson Cancer Center.  

Dr. Raut currently serves as Chair of the AJCC Soft Tissue Sarcoma Staging Panel (9th edition), Co-Chair of the Surgery Committee in the cancer cooperative group Alliance for Clinical Trials in Oncology, and Treasurer on the Executive Board of the Connective Tissue Oncology Society.  In 2013, he co-founded the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.  He is the former Program Director of the Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship Program at Harvard Medical School.  He serves as Section Editor for sarcoma in the journals Cancer and Surgical Oncology Insights.  He has authored over 300 papers and over 30 book chapters.